199 related articles for article (PubMed ID: 19672785)
1. Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland.
Nakajima Y; Kishimoto T; Nagai Y; Yamada M; Iida Y; Okamoto Y; Ishida Y; Nakatani Y; Ichinose M
Pathology; 2009; 41(7):634-9. PubMed ID: 19672785
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.
DeRoche TC; Hoschar AP; Hunt JL
Arch Pathol Lab Med; 2008 Dec; 132(12):1907-11. PubMed ID: 19061288
[TBL] [Abstract][Full Text] [Related]
4. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
[TBL] [Abstract][Full Text] [Related]
6. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
8. A low percentage of HER-2 amplification whereas indicates poor prognosis in salivary carcinoma ex pleomorphic adenoma: a study of 140 cases.
Xia L; Hu Y; Li J; Gu T; Zhang C; Wang L; Tian Z
J Oral Pathol Med; 2017 Mar; 46(3):167-174. PubMed ID: 27423271
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
Di Palma S
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
[TBL] [Abstract][Full Text] [Related]
11. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a subset of tumor suppressor gene for copy number and epigenitic changes in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma carcinogenesis.
Mariano FV; Egal ES; Pramio D; Fidalgo F; Sara É; Costa AF; de Oliveira Gondak R; Coletta RD; de Almeida OP; Kowalski LP; Victorino Krepischi AC; Altemani A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):322-31. PubMed ID: 27544395
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
Kim JW; Kwon GY; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
J Korean Med Sci; 2011 Oct; 26(10):1277-85. PubMed ID: 22022178
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.
Kim H; Eun S; Jeong WJ; Ahn SH; Bae YJ; Lee JS; Kim H
Sci Rep; 2022 Aug; 12(1):13383. PubMed ID: 35927424
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: relationship to prognosis.
Müller S; Vigneswaran N; Gansler T; Gramlich T; DeRose PB; Cohen C
Mod Pathol; 1994 Aug; 7(6):628-32. PubMed ID: 7991521
[TBL] [Abstract][Full Text] [Related]
18. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma ex-pleomorphic adenoma derived from recurrent pleomorphic adenoma shows important difference by array CGH compared to recurrent pleomorphic adenoma without malignant transformation.
Mariano FV; Giovanetti K; Saccomani LF; Del Negro A; Kowalski LP; Krepischi AC; Altemani A
Braz J Otorhinolaryngol; 2016; 82(6):687-694. PubMed ID: 26971045
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
